METHOD FOR VIRUS PRODUCTION
The invention relates to a method of increasing the yield of virus, virus particles, or viral vectors from host cells in a fixed-bed bioreactor by specifically modifying the dissolved oxygen levels in the media.
1 . A method of producing virus in a bioreactor comprising the following steps:
a) providing host cells in the bioreactor;
b) growing host cells in a constant initial dO 2 level, pH, and temperature;
c) decreasing the dO 2 to 20-90% of initial oxygen level;
d) infecting the host cells with at least one virus or virus particle 2-24 hours after step c);
e) incubating said host cells infected with said virus or virus particle to propagate said virus; and
f) harvesting the virus.
2 . The method of claim 1 , wherein the host cells are adherent cells.
3 . The method of claim 1 , wherein the bioreactor is a flat-bed bioreactor.
4 . The method of claim 1 , wherein the height of the fixed-bed is 2 cm to 10 cm.
5 . The method of claim 1 , wherein the bioreactor is a single-use flat-bed bioreactor.
6 . The method of claim 1 , wherein said dO 2 level in step c is decreased to 20-50%.
7 . The method of claim 1 , wherein said dO 2 level in step c is decreased when the conductivity is 60 mS/cm to 80 mS/cm.
8 . The method of claim 1 , wherein the host cell in step d is infected with a virus when the conductivity is 90 mS/cm to 110 mS/cm.
9 . The method of claim 1 , wherein the infection of the host cells with the virus is at multiplicity of infection (MOI) of about 0.1 to 0.05.
10 . The method of claim 1 , wherein, the infection of the host cells with the virus is at MOI of 0.05.
11 . The method of claim 1 , wherein the dO 2 in step c is decreased 12 to 24 hours prior to infecting the host cell in step d.
12 . The method of claim 1 , wherein the virus is selected from a group consisting of VSV, adenovirus, Influenza virus, Ross River virus, Hepatitis A virus, Vaccinia virus and recombinant Vaccinia virus, Herpes Simplex virus, Japanese Encephalitis virus, Herpes Simplex virus, West Nile virus, Yellow Fever virus, and chimeras thereof, as well as Rhino virus and Reovirus.
13 . The method of claim 1 , wherein the virus is a viral vector.
14 . (canceled)
15 . The method of claim 1 , wherein the host cells are selected from the group consisting of Vero cells, MBCK cells, MDBK cells, MRC-5 cells, BSC-1 cells, LLC-MK cells, CV-1 cells, CHO cells, COS cells, murine cells, human cells, avian cells, insect cells, HeLa cells, 293 cells, MDOK cells, CRFK cells, RAF cells, TCMK cells, LLC-PK cells, PK 15 cells, W1-38 cells, T-FLY cells, BHK cells, SP2/0 cells, NSO cells, and PerC6 cells.
16 . (canceled)
17 . The method of claim 1 , further comprising the step of determining the virus titer by plaque assay method.
18 . The method of claim 1 , further comprising the step of purifying and or characterizing of the virus.
19 . The method of claim 1 , further comprising the step of producing a vaccine with said virus.
20 . The method of claim 1 , wherein the bioreactor has a capacity of 700 to 800 mL or has a capacity of 50 to 80 L.
21 . (canceled)
22 . The method of claim 1 , wherein the bioreactor includes protein-free media.
23 . A method of producing virus in a bioreactor comprising the following steps:
a) providing host cells in the bioreactor;
b) growing host cells in a constant initial dO 2 level, pH, and temperature to confluence;
c) decreasing the dO 2 to 20-50% of initial dO 2 level;
d) infecting the host cells with at least one virus or virus particle;
e) incubating said host cells infected with said virus or virus particle to propagate said virus; and
f) harvesting the virus.